K Ci is the potassium salt of citric acid, widely used as a dietary supplement to prevent or treat low blood potassium. Understanding how old K Ci is helps contextualize its history in medicine and food science.
Manufacturers have formulated K Ci into tablets, capsules, and powders for decades, making it a familiar option for potassium supplementation. This timeline shapes how clinicians and consumers view its safety and effectiveness today.
| Name | Chemical Identity | Common Use | Typical Form | Regulatory Status |
|---|---|---|---|---|
| K Ci | Potassium citrate | Potassium supplement, kidney stone management | Tablets, capsules, powder | FDA regulated supplement/pharmaceutical |
| First approved | 1970s–1980s (pharmaceutical) | 1990s (dietary supplement) | Management of hypokalemia and metabolic alkalosis | Immediate- and extended-release tablets | USP verified where available |
| Key milestone | 1980s (clinical adoption) | 2000s (mass-market supplements) | Kidney stone prevention protocols | Buffered formats and effervescent powders | Label standardization by regulatory bodies |
| Typical dosing | 8 mEq to 16 mEq per dose, up to 100 mEq/day under supervision | Daily maintenance or therapeutic correction | Dosed per milliequivalent (mEq) | Monitoring of serum potassium and renal function |
History of Potassium Citrate as a Supplement
The history of K Ci dates back to mid-20th century chemistry, where potassium citrate was studied for buffering acid in the body. Early intravenous and oral formulations appeared in hospitals in the 1960s and 1970s to manage electrolyte imbalances.
By the 1980s, physicians widely prescribed potassium citrate to prevent calcium kidney stones, particularly in people with metabolic acidosis. This clinical use laid the groundwork for today’s over-the-counter supplements.
How K Ci Is Produced and Tested
Manufacturers produce K Ci by reacting citric acid with potassium carbonate or potassium hydroxide, followed by purification and crystallization. Quality control testing ensures correct potassium content, absence of contaminants, and stability in different formulations.
Third-party verification programs check label accuracy and tablet disintegration, helping consumers confirm that the product matches what is claimed on the packaging. These standards support consistent safety and performance over time.
Dosage, Safety, and Regulation
Regulatory agencies classify potassium citrate as both a pharmaceutical ingredient and a dietary supplement, depending on the intended use. Therapeutic dosages for hypokalemia are typically higher and supervised, while supplement doses are lower and aimed at nutritional support.
Common side effects include gastrointestinal discomfort, and taking K Ci with food can reduce irritation. Individuals with kidney disease or those on potassium-sparing medications should consult a healthcare professional before starting supplementation.
Formulations and Product Evolution
Over time, K Ci has evolved into fast-dissolving powders, chewable tablets, and effervescent sachets to improve taste and convenience. Extended-release formulations aim to support steady potassium absorption and reduce dosing frequency.
These advances reflect broader trends in supplement technology, where user experience, compliance, and stability drive innovation in how potassium citrate reaches consumers.
Key Takeaways on K Ci Usage
- K Ci has been used in medicine since the 1970s and as a commercial supplement since the 1990s.
- Its production relies on controlled acid-base reactions and rigorous purity testing.
- Standard dosing is guided by potassium content, with therapeutic protocols differing from maintenance use.
- Ongoing product innovations focus on taste, convenience, and targeted release for better adherence.
FAQ
Reader questions
When was K Ci first used as a medication?
K Ci began to be used as a medication in the 1970s and 1980s, primarily in hospital settings to correct hypokalemia and to manage kidney stone risk in patients with metabolic alkalosis.
How does the age of K Ci compare to newer potassium supplements?
Because potassium citrate has been studied and used for decades, K Ci is older than many newer forms such as potassium glycinate or chelated potassium, which emerged later to address taste and gastrointestinal issues.
Why does the FDA regulate K Ci as both a drug and a supplement?
The FDA regulates K Ci as a drug when it is used to treat diagnosed conditions like hypokalemia, and as a supplement when marketed for general nutritional support, based on labeling and intended use. Clinical studies since the 1980s show that potassium citrate reduces kidney stone recurrence by raising urine citrate and alkalinizing urine, forming a strong evidence base that continues to inform medical guidelines.